Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trialDaniel V.T. Catenacci, Yung‐Jue Bang, Haeseong Park et al.|The Lancet Oncology|2020Cited by 190
Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancerAn Na Seo, Jong Gwang Kim|British Journal of Cancer|2017Cited by 48